Ledipasvir D-tartrateCAS# 1502654-87-6 |
Related Products
- LDK378
Catalog No.:BCC3691
CAS No.:1032900-25-6
- AP26113
Catalog No.:BCC1069
CAS No.:1197958-12-5
- AZD-3463
Catalog No.:BCC3907
CAS No.:1356962-20-3
- SB525334
Catalog No.:BCC2531
CAS No.:356559-20-1
- TAE684 (NVP-TAE684)
Catalog No.:BCC3660
CAS No.:761439-42-3
- (R)-Crizotinib
Catalog No.:BCC1284
CAS No.:877399-52-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1502654-87-6 | SDF | Download SDF |
| PubChem ID | 78357794 | Appearance | Powder |
| Formula | C53H60F2N8O12 | M.Wt | 1039.09 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | GS-5885 D-tartrate | ||
| Solubility | DMSO : ≥ 28 mg/mL (26.95 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | (2S,3S)-2,3-dihydroxybutanedioic acid;methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate | ||
| SMILES | CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.C(C(C(=O)O)O)(C(=O)O)O | ||
| Standard InChIKey | ZQVLPYMRXLPMDX-KEAIDYLOSA-N | ||
| Standard InChI | InChI=1S/C49H54F2N8O6.C4H6O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6;5-1(3(7)8)2(6)4(9)10/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63);1-2,5-6H,(H,7,8)(H,9,10)/t29-,30+,38-,39-,40-,41-;1-,2-/m00/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Ledipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.In Vitro:Ledipasvir has GT1a and 1b EC50 values of 31 and 4 pM, respectively, and protein-adjusted EC50 values of 210 pM (GT1a) and 27 pM (GT1b) and the intrinsic EC50 of 39 is 310 fM for GT1a and 40 fM for GT1b. Ledipasvir is highly protein-bound both in human serum and in the cell-culture medium (containing 10% BSA) of the replicon assay[1]. Ledipasvir exhibits an EC50 value of 141 nM against the JFH/3a-NS5A replicon[2].In Vivo:Ledipasvir is remarkable not only on the basis of its high replicon potency but also on the basis of its low clearance, good bioavailability, and long half-lives in rat, dog, and monkey and low predicted clearance in human. The pharmacokinetics of Ledipasvir is measured in rats and dogs. Ledipasvir shows good half-lives (rat 1.83 ± 0.22 hr, dog 2.63 ± 0.18 hr) in plasma, low systemic clearance (CL), and moderate volumes of distribution (Vss) that are greater than total body water volume[1]. References: | |||||
Ledipasvir D-tartrate Dilution Calculator
Ledipasvir D-tartrate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.9624 mL | 4.8119 mL | 9.6238 mL | 19.2476 mL | 24.0595 mL |
| 5 mM | 0.1925 mL | 0.9624 mL | 1.9248 mL | 3.8495 mL | 4.8119 mL |
| 10 mM | 0.0962 mL | 0.4812 mL | 0.9624 mL | 1.9248 mL | 2.406 mL |
| 50 mM | 0.0192 mL | 0.0962 mL | 0.1925 mL | 0.385 mL | 0.4812 mL |
| 100 mM | 0.0096 mL | 0.0481 mL | 0.0962 mL | 0.1925 mL | 0.2406 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Ledipasvir (GS5885) D-tartrate is an inhibitor of the hepatitis C virus NS5A protein, which is an experimental drug for the treatment of hepatitis C.
Featured Products
- Fmoc-p-amino-benzoic acid,Fmoc-4-Abz-OH
Catalog No.:BCC2622
CAS No.:15026-42-1
- Fmoc-2-Abz-OH
Catalog No.:BCC3204
CAS No.:150256-42-1
- 12-Deoxo-12alpha-acetoxyelliptone
Catalog No.:BCN4803
CAS No.:150226-21-4
- Trigothysoid N
Catalog No.:BCN6881
CAS No.:1501943-08-3
- BIM 23056
Catalog No.:BCC5824
CAS No.:150155-61-6
- Crucigasterin 225
Catalog No.:BCN1786
CAS No.:150151-85-2
- Crucigasterin 275
Catalog No.:BCN1776
CAS No.:150151-84-1
- Crucigasterin 277
Catalog No.:BCN1777
CAS No.:150151-83-0
- 11,13-Dihydroivalin
Catalog No.:BCN4705
CAS No.:150150-61-1
- Strictosidinic acid
Catalog No.:BCN6965
CAS No.:150148-81-5
- (S)-MCPG
Catalog No.:BCC6611
CAS No.:150145-89-4
- Qianhucoumarin A
Catalog No.:BCN3615
CAS No.:150135-35-6
New Products
- H-Aib-Ome.HCl
Catalog No.:BCC2671
CAS No.:15028-41-8
- Z-Aib-OH
Catalog No.:BCC3150
CAS No.:15030-72-5
- Prasugrel
Catalog No.:BCC1089
CAS No.:150322-43-3
- Cyclopropyl 2-fluorobenzyl ketone
Catalog No.:BCC8923
CAS No.:150322-73-9
- Quipazine dimaleate
Catalog No.:BCC6727
CAS No.:150323-78-7
- threo-7-O-Methylguaiacylglycerol beta-coniferyl ether
Catalog No.:BCN6929
CAS No.:150333-85-0
- Sivelestat sodium salt
Catalog No.:BCC2368
CAS No.:150374-95-1
- SR 49059
Catalog No.:BCC7324
CAS No.:150375-75-0
- MRS 2690
Catalog No.:BCC7514
CAS No.:15039-58-4
- Pemetrexed disodium
Catalog No.:BCN2179
CAS No.:150399-23-8
- o-Methoxycinnamaldehyde
Catalog No.:BCN3860
CAS No.:1504-74-1
- L-NIL hydrochloride
Catalog No.:BCC5706
CAS No.:150403-89-7
Ledipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.
Ledipasvir D-tartrate,1502654-87-6,GS-5885 D-tartrate,Natural Products,HCV, buy Ledipasvir D-tartrate , Ledipasvir D-tartrate supplier , purchase Ledipasvir D-tartrate , Ledipasvir D-tartrate cost , Ledipasvir D-tartrate manufacturer , order Ledipasvir D-tartrate , high purity Ledipasvir D-tartrate
